PATRICK ENRIGHT

Profile

First Name

: PATRICK

Middle Name

:

Last Name

: ENRIGHT

Related Companies
Titles
Company Name
Related People
DIRECTOR
XANODYNE PHARMACEUTICALS INC
KEVIN T. ANDERSON, TIMOTHY ARENDT, ROLF A. CLASSON, DANIEL W. DOCHERTY, NATASHA GIORDANO, THOMAS P. JENNINGS, VAUGHAN M. KAILIAN, VAUGHN M. KAILIAN, RITA M. O-CONNOR, DENNIS PURCELL, GARY A. SHANGOLD, JAMES SHANNON, STEPHEN ST. PETER, STEVEN ST. PETER, STEPHEN A. STAMP, CRAIG TOOMAN, MICHAEL VALENTINO, PETER WENTWORTH
DIRECTOR
CARDIODX INC
BROOK BYERS, BROOK H. BYERS, GWEN R. CARSCADDEN, FRED COHEN, SUSAN DANIELS, PATRICK G. ENRIGHT, WILLIAM ERICSON, MICHAEL GOLDBERG, MELINDA GRIFFITH, ANDREW L. GUGGENHIME, JEFF HEER, TIM HENN, HONGJIE HU, DEBORAH L. KILPATRICK, LOUIS G. LANGE, DAVID LEVISON, DAVID L. LEVISON, KHUSHRO F. MEHTA, MARK MONANE, ARTHUR M. PAPPAS, AMY PAYE, STEVEN ROSENBERG, DOUGLAS T. ROSS, AJIT SINGH, RISA STACK, JAMES R. TOBIN, RAFAEL TORRES, MARK WEEKS, ROBERT F. WERNER, DUANE WILLIAMS, MARK .R. WILLIG, JIM WINGROVE
EXECUTIVE OFFICER, DIRECTOR
LONGITUDE VENTURE PARTNERS II, L.P.
JULIET TAMMENOMS BAKKER
DIRECTOR
INFACARE PHARMACEUTICAL CORP
PETER BARRETT, DAN BURNS, WILLIAM CROUSE, E. RONALD GOLDFUSS, RON GOLDFUSS, RICHARD VIETOR, ROBERT VUKOVICH, HAROLD WERNER
DIRECTOR
ESPERION THERAPEUTICS, INC.
ALISON DE BORD, PATRICK G. ENRIGHT, DOV GOLDSTEIN, DOV A. GOLDSTEIN, ANTONIO M. GOTTO, JR., TROY A. IGNELZI, DANIEL JANNEY, ALISON KILEY, LOUIS LANGE, LOUIS G. LANGE, TIM M. MAYLEBEN, TIMOTHY M. MAYLEBEN, MARK E. MCGOVERN, ROGER S. NEWTON, GILBERT S. OMENN, NOAH L. ROSENBERG, NICOLE VITULLO
DIRECTOR
ALLERGEN RESEARCH CORP
DANIEL C. ADELMAN, SUSAN E. BARROWCLIFFE, GREGORY BEHAR, ERIC H. BJERKHOLT, VICTOR COLUNGA, JAYSON D.A. DALLAS, STEPHEN G. DILLY, JR., PATRICK G. ENRIGHT, KATHRYN E. FALBERG, BRETT K. HAUMANN, MARK T. IWICKI, JEFFREY H. KNAPP, MARK D. MCDADE, MARY M. ROZENMAN, STACEY D. SELTZER, DOUGLAS T. SHEEHY, JAMES TANANBAUM, BRYAN L. WALSER, JOONKYOO (ANTHONY) YUN
DIRECTOR
SUTROVAX, INC.
DURGA P BOBBA, JEFF FAIRMAN, PATRICK HERON, PATRICK J HERON, PETER HIRTH, ROB HOPFNER, ASHISH KHANNA, HEATH LUKATCH, WILLIAM NEWELL, WILLIAM J NEWELL, GRANT PICKERING, GRANT E PICKERING, TRACY SAXTON, MONCEF SLAOUI, ELAINE SUN, KURT VON EMSTER, JAMES P WASSIL, JANE WRIGHT-MITCHELL
DIRECTOR
ORBUS THERAPEUTICS, INC.
ELISHA (TERRY) GOULD, JASON D. LEVIN, ERNEST MARIO, ROBERT M. MYERS, KURT VON EMSTER, MICHAEL WASSERMAN
EXECUTIVE OFFICER, DIRECTOR
LONGITUDE VENTURE PARTNERS III, L.P.
JULIET TAMMENOMS BAKKER
EXECUTIVE OFFICER
ROCK STARR LLC
BRUCE YAP
EXECUTIVE OFFICER
ROCKPOINT LLC
BRUCE YAP
DIRECTOR
APTINYX INC.
PATRICK G. ENRIGHT, WILBUR H. GANTZ III, TERRY P. GOULD, ASHISH KHANNA, ANDREW D. KIDD, ADAM M. KOPPEL, TORSTEN M. MADSEN, JOSEPH R. MOSKAL, LIAM RATCLIFFE, NORBERT G. RIEDEL, JAMES TOPPER, JAMES N. TOPPER
DIRECTOR
CURASEN THERAPEUTICS, INC.
ANTHONY P FORD, ANTHONY P. FORD, KATHLEEN SEREDA GLAUB, RON HUNT, BENJAMIN POTTER, LIAM RATCLIFFE, HENRY SKINNER, SIMON TATE, SIMON TATE, PH.D., LORETTA TSE, PH.D.
EXECUTIVE OFFICER
STICHTING ADMINISTRATIEKANTOOR SYNCREON
DAN AVRAMOVICH, WILLIAM GRYZENIA, KENNETH POCIUS, PETER WALLER
DIRECTOR
VERA THERAPEUTICS, INC.
ANDREW CHENG, MARSHALL FORDYCE, MAHA KATABI, SCOTT MORRISON, BETH SEIDENBERG, KURT VON EMSTER
DIRECTOR
RIVUS PHARMACEUTICALS, INC.
ALLEN CUNNINGHAM, JAYSON DALLAS, FRANCESCO DE RUBERTIS, DEREK DIROCCO, NANCY HARGREAVES, SHAHARYAR KHAN, ERIN LAVELLE, TOM O-NEIL, ROBERT SCHOTT, IAN SMITH, RICK WINNINGHAM
EXECUTIVE OFFICER
LONGITUDE VENTURE PARTNERS V, L.P.
N/A LONGITUDE CAPITAL PARTNERS V, LLC, JULIET TAMMENOMS BAKKER
EXECUTIVE OFFICER
LONGITUDE PRIME FUND II, L.P.
N/A LONGITUDE PRIME PARTNERS II, LLC, JULIET TAMMENOMS BAKKER
DIRECTOR
BIOAGE LABS, INC.
JASON COLOMA, KRISTEN FORTNEY, DOV GOLDSTEIN, JAMES HEALY, REHKA HEMRAJANI, ERIC MORGEN, VIJAY PANDE
DIRECTOR
VERADERMICS, INC
AMANDA BIRDSEY-BENSON, DOMINIC CARRANO, JOHN CHILDS, JOHN W. CHILDS, VLADIMIR CORIC, TIM DURSO, TIMOTHY DURSO, DAVID FRIEDMAN, JANE GRANT-KELS, MICHAEL GRECO, MARK NEUMANN, KATARINA PANCE, REID WALDMAN
EXECUTIVE OFFICER
LONGITUDE 103.8 EAST, L.P.
N/A LONGITUDE 103.8 EAST PARTNERS, LLC, JULIET TAMMENOMS BAKKER
DIRECTOR
INFINANT HEALTH, INC.
AMANDA BIRDSEY-BENSON, MICHAEL JOHNSON, KATHARINE KNOBIL, MIKE LIANG, LAURA STOPPEL, ROGER WYSE
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-06-08
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2026-05-21 
2026-05-15
D
Link
OTHER HEALTH CARE 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2026-05-01 
2025-11-13
D
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2025-11-04 
2025-10-28
D
Link
OTHER HEALTH CARE 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2025-10-14 
2024-09-18
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-08-26 
2024-02-13
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-02-01 
2023-10-12
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-11-01 
2023-07-20
D/A
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2022-08-01 
2023-07-20
D/A
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2022-08-01 
2022-11-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-11-01 
2021-11-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-10-21 
2021-10-04
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2019-03-26 
2021-02-25
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-10-29 
2020-10-16
D
Link
BUSINESS SERVICES 
 
DECLINE TO DISCLOSE 
 
2020-10-01 
2020-08-11
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-07-27 
2020-04-03
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2020-03-20 
2019-03-20
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-08-08 
2019-01-25
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-09-18 
2018-06-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-05-29 
2017-12-21
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2017-12-15 
2017-08-15
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-08-08 
2017-06-07
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
 
2017-05-24 
2017-06-01
D
Link
RETAILING 
 
DECLINE TO DISCLOSE 
Equity 
2017-05-25 
2017-04-20
D
Link
RETAILING 
 
DECLINE TO DISCLOSE 
Equity 
2015-05-22 
2017-03-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-03-03 
2016-11-04
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
 
2016-10-26 
2016-06-23
D/A
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
Equity 
2016-05-11 
2015-08-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-08-07 
2015-07-24
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-07-10 
2015-07-08
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-06-24 
2015-03-24
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2015-01-20 
2014-12-09
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2014-12-08 
2014-10-21
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2014-10-20 
2014-07-15
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2014-06-30 
2013-03-20
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2013-03-08 
2012-10-23
D/A
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
Equity 
2011-08-31 
2012-09-05
D/A
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
Equity 
2011-08-31 
2012-08-31
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-08-16 
2011-09-14
D
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
Equity 
2011-08-31 
2011-03-02
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-02-17 
2009-10-30
D/A
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2009-05-15